1M7

CAMBR.COGNIT.HLDGS LS-01

Healthcare · EUR · F

1M7

Price

€0.36

-0.28%

Cap

€16.53M

Earnings

30d Trend

-7.9%

1M7
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityModerate

40% annualised over 90 days

BRAIN47 SIGNAL

0
WEAK
Risk Level74
Quality15
Momentum55
Technical40
Fundamentals18

Raw weighted: 30×Macro 0.99 (1%)=30

RISK

74/100
90d Volatility
39.5%High
ATR %
5.4%High daily moves
Max Drawdown (1Y)
-35.9%Volatile

QUALITY

15/100
Piotroski F-Score
1/9Weak
Margin Stability
CV 76.0%Volatile

MOMENTUM

55/100
12-1M Momentum
-5.1%Downtrend
6-1M Momentum
+12.2%Positive
1M Return
-4.2%Recent pullback

TECHNICAL

40/100
RSI (14)
30.2Neutral
Price vs SMA200
-1.2%Flat
MACD
-0.01Bearish momentum
Bollinger Band
22%Mid-range
SMA Cross
Death CrossDeath Cross
Trend Quality (KER)
0.333Mixed

FUNDAMENTALS

18/100
P/S
31.9Expensive
Shareholder Yield
0.0%Low

Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months46
3-12 months37
1-5+ years22

Limited short-term thesis

BRAIN47'S ASSESSMENT

I rate CAMBR.COGNIT.HLDGS LS-01 at 30/100 — a WEAK reading on the Brain47 Signal. The strongest factor is momentum at 55/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.

PAST PERFORMANCE

1 MONTH

-4.2%

3 MONTHS

-21.8%

12 MONTHS

-9.3%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Limited short-term thesis. Momentum (55) and Technical (40) are the primary strengths. I note that quality is the weakest area at 15/100 — this warrants monitoring. Historical volatility is moderate at 40%. I classify this as a speculative position — risk characteristics and smaller market cap define the opportunity.

speculativeScore: 30/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.